Furthermore, the average serum PCSK9 concentration was significantly higher in CAD patients than that in healthy individuals, whereas LDL-C was lower in CAD patients than healthy individuals because of the strict statin treatment, implying the presence of inflammatory residual risk even after statin therapy in patients with CAD (Fig. 10b). The gene discussed is PCSK9; the disease is coronary artery disorder.